Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona Gaughran

Showing results (161-170 of 190) with videos related to

Pageof 19
Sort By:
Bjpsych Open|October 4, 2024
Evaluating a volunteer 'Health Champions' intervention supporting people with severe mental illness to manage their physical health: feasibility hybrid randomised controlled trialJulie Williams, Ray McGrath, Karen Ang, et al.
BMC Psychiatry|December 30, 2017
Randomised control trial of the effectiveness of an integrated psychosocial health promotion intervention aimed at improving health and reducing substance use in established psychosis (IMPaCT)Fiona Gaughran, Daniel Stahl, Khalida Ismail, et al.
Schizophrenia Research|July 30, 2017
Utilising symptom dimensions with diagnostic categories improves prediction of time to first remission in first-episode psychosisOlesya Ajnakina, John Lally, Marta Di Forti, et al.
Schizophrenia Bulletin|March 7, 2026
Clinical Practice Guideline on the Choice of First Antipsychotic Medicine for Females Experiencing a First-Episode of PsychosisCaroline Hynes-Ryan, Dolores Keating, Aoife Carolan, et al.
Schizophrenia Research|July 31, 2017
Hyperprolactinaemia in first episode psychosis - A longitudinal assessmentJohn Lally, Olesya Ajnakina, Brendon Stubbs, et al.
Schizophrenia Research|January 1, 2016
Substance use, medication adherence and outcome one year following a first episode of psychosisMarco Colizzi, Elena Carra, Sara Fraietta, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|September 28, 2018
EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH)Brendon Stubbs, Davy Vancampfort, Mats Hallgren, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 13, 2017
Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controlsChristoph U Correll, Marco Solmi, Nicola Veronese, et al.
The British Journal of Psychiatry : the Journal of Mental Science|May 15, 2026
New approaches to clinical research for people with schizophreniaKatherine Beck, Matthew Broome, Saeed Farooq, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 19, 2022
Real-world clinical and cost-effectiveness of community clozapine initiation: mirror cohort studyEmma Butler, Toby Pillinger, Kirsten Brown, et al.
Pageof 19

Showing results (161-170 of 190) with videos related to

Sort By:
Pageof 19
Bjpsych Open|October 4, 2024
Evaluating a volunteer 'Health Champions' intervention supporting people with severe mental illness to manage their physical health: feasibility hybrid randomised controlled trialJulie Williams, Ray McGrath, Karen Ang, et al.
BMC Psychiatry|December 30, 2017
Randomised control trial of the effectiveness of an integrated psychosocial health promotion intervention aimed at improving health and reducing substance use in established psychosis (IMPaCT)Fiona Gaughran, Daniel Stahl, Khalida Ismail, et al.
Schizophrenia Research|July 30, 2017
Utilising symptom dimensions with diagnostic categories improves prediction of time to first remission in first-episode psychosisOlesya Ajnakina, John Lally, Marta Di Forti, et al.
Schizophrenia Bulletin|March 7, 2026
Clinical Practice Guideline on the Choice of First Antipsychotic Medicine for Females Experiencing a First-Episode of PsychosisCaroline Hynes-Ryan, Dolores Keating, Aoife Carolan, et al.
Schizophrenia Research|July 31, 2017
Hyperprolactinaemia in first episode psychosis - A longitudinal assessmentJohn Lally, Olesya Ajnakina, Brendon Stubbs, et al.
Schizophrenia Research|January 1, 2016
Substance use, medication adherence and outcome one year following a first episode of psychosisMarco Colizzi, Elena Carra, Sara Fraietta, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|September 28, 2018
EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH)Brendon Stubbs, Davy Vancampfort, Mats Hallgren, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 13, 2017
Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controlsChristoph U Correll, Marco Solmi, Nicola Veronese, et al.
The British Journal of Psychiatry : the Journal of Mental Science|May 15, 2026
New approaches to clinical research for people with schizophreniaKatherine Beck, Matthew Broome, Saeed Farooq, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 19, 2022
Real-world clinical and cost-effectiveness of community clozapine initiation: mirror cohort studyEmma Butler, Toby Pillinger, Kirsten Brown, et al.
Pageof 19